Legend Biotech Corporation Q3 Loss Decreases

(RTTNews) - Legend Biotech Corporation (LEGN) reported Loss for third quarter of -$39.69 million

The company's earnings came in at -$39.69 million, or -$0.11 per share. This compares with -$125.32 million, or -$0.34 per share, last year.

Excluding items, Legend Biotech Corporation reported adjusted earnings of -$18.78 million or -$0.05 per share for the period.

The company's revenue for the period rose 70.0% to $272.33 million from $160.21 million last year.

Legend Biotech Corporation earnings at a glance (GAAP) :

-Earnings: -$39.69 Mln. vs. -$125.32 Mln. last year. -EPS: -$0.11 vs. -$0.34 last year. -Revenue: $272.33 Mln vs. $160.21 Mln last year.